The Why: The Philadelphia Tragedy that Changed Gene Therapy

Freelance writer Meir Rinde talks about his recent Distillations article on gene therapy with WHYY’s The Why.

Twenty years ago, 18-year-old Jesse Gelsinger died after taking part in a clinical trial for gene therapy at the University of Pennsylvania. The tragedy sent shock waves through Philadelphia’s biotech industry and across the medial world. Meir Rinde, who wrote about the case for the Science History Institute’s Distillations, explains why Gelsinger’s death changed gene therapy.

Listen to the podcast on The Why.